Bills: HB1168

Keywords: abortion, abortion-inducing drugs, medication abortion, mifepristone, misoprostol, methotrexate, pro-life, pro-choice, reproductive health, unborn child, trafficking, felony, contraception, pharmacist, pharmacy, Title 63, Oklahoma statutes, abortion pill, drug distribution, criminal penalty

Transcript Highlights:

• So, are you aware that mifepristone has been used by more than 5 million People since the FDA first approved
• individuals who may have taken this medication for miscarriage management, because are you aware that mifepristone

Bills: HB1168

Keywords: abortion, abortion-inducing drugs, medication abortion, mifepristone, misoprostol, methotrexate, pro-life, pro-choice, reproductive health, unborn child, trafficking, felony, contraception, pharmacist, pharmacy, Title 63, Oklahoma statutes, abortion pill, drug distribution, criminal penalty

Bills: HB216

Keywords: HB216, Texas abortion law, abortion-inducing drug, medication abortion, mifepristone, misoprostol, telemedicine, in-person exam, physician presence, out-of-state physician, reproductive healthcare, abortion regulation, Health and Safety Code, Occupations Code, consultation services, remote prescribing, pro-life, pro-choice

Summary: The Committee on Public Health met with a quorum and heard public testimony on a long agenda, with members repeatedly reminded of a two-minute limit for witnesses. Several bills were voted out favorably, including HB 2588 on cottage food, HB 1639 on cancer incidence and female firefighters, HB 2581 on a reporting form for contracted services for pregnant women, and SB 922 on electronic disclosure of certain sensitive medical information. Those measures generally passed on party-line or near-unanimous votes, while HB 216 on itemized medical statements was left pending after the committee substitute was withdrawn. The committee also left pending HB 5141, HB 4638, HB 2035, HB 4813, HB 2264, HB 4014, and HB 3829 after hearing testimony and questions. The final item introduced in the excerpt was HB 4408 on health care market transparency and corporate consolidation, but the discussion was cut off before testimony or action was completed. A major theme of the hearing was mental health diversion and access to treatment. HB 5141, by Rep. Howard, would allow Travis County to use vacated Austin State Hospital property for a local mental health jail diversion center; law enforcement, the Travis County sheriff, county judge, and urban counties group all testified in support, describing the lack of alternatives for people in crisis and the burden on jails and emergency rooms. Members asked about eligible offenses, bed capacity, and whether the facility would serve only Travis County, and the bill was left pending. HB 2264, by Rep. Schoolcraft, would create a friends-and-family form for loved ones to provide information to providers during emergency mental health treatment; NAMI and hospital groups supported it, while one neutral witness and several members raised concerns about patient control, credibility of information, and liability protections. The bill was also left pending. The committee also heard multiple psychedelic-therapy and drug-policy bills. HB 4813 would speed Texas rescheduling of Schedule I substances if the FDA reclassifies them, with testimony focused on psilocybin and MDMA and their potential use for PTSD and depression; members questioned whether the bill was too broad and how state rescheduling works, and it was left pending. HB 4014 would direct HHSC to study psychedelic therapies, building on prior state research, and witnesses said Texas should prepare regulatory and clinical infrastructure before FDA approval; it too was left pending. HB 2035 would require parents to be informed that they may seek substance-use treatment for a child even if one facility turns them away, prompted by a constituent’s account of a fatal fentanyl overdose after receiving incorrect advice; it was left pending. HB 4638 would extend and expand the Texas Pharmaceutical Initiative board and timeline, with the author saying the program is still in early implementation and needs more time, and it was left pending as well. Other bills addressed public health administration and animal welfare. HB 3829 would require a study of the animal-friendly account and its grant process for spay/neuter funding, with the author arguing that the current application and reimbursement process is too burdensome for shelters and nonprofits; no opposition was heard and the bill was left pending. HB 2581 and HB 1639 were reported favorably, while HB 216 drew discussion about enforcement of itemized medical billing and was held after the committee substitute was withdrawn. Throughout the hearing, members also discussed broader concerns about homelessness, competency restoration waitlists, jail overcrowding, and the need for more treatment options outside the criminal justice system.

Bills: HB195, HB247, HB255, HJR6, HJR31, HJR34

Keywords: HB 195, Texas Controlled Substances Act, Schedule IV, controlled substances, mifepristone, misoprostol, carisoprodol, Health and Safety Code, drug scheduling, pharmacy regulation, prescription drugs, reproductive health, abortion medication, medication abortion, women's health, prescribing, dispensing, law enforcement, drug control, education reform

Transcript Highlights:

• So, Mifepristone and Misoprostol have other functions? Correct.
• On that, but that is an FDA-approved indication for the use of Mifepristone.
• We don't use Mifepristone for hypertension; it's not even on label.
• Mifepristone...
• To try to save a pregnancy where Mifepristone was given.

Bills: SB10, SB16, SB6, SB 6, SB 10, SB 16

Keywords: trafficking, prostitution, affirmative defense, victims, criminal justice reform, victim rights, criminal justice, judicial reform, court procedures, mental health services, criminal penalties, court security, SB 6, Woman and Child Protection Act, abortion, abortion-inducing drugs, medication abortion, mifepristone, misoprostol, pro-life

Bills: HB195, HB247, HB255, HJR2, HJR4, HJR6, HJR31, HJR34, HB195, HB247, HB255, HJR6, HJR31, HJR34

Keywords: school district, ad valorem tax, local revenue, tax collection, education funding, border security, tax exemption, ad valorem, real property, infrastructure, Texas-Mexico border, ad valorem taxation, farm products, livestock, timber, death tax, inheritance tax, estate tax, property transfer, constitutional amendment

Transcript Highlights:

• It protects access to medication abortion here in California, specifically mifepristone, a common and
• , and hospitals from disciplinary actions or licensing impacts when they are legally providing mifepristone
• Further, by removing providers' names from mifepristone prescription labels, this bill takes additional
• This bill recklessly removes critical safeguards from the dispensing of abortion pills like mifepristone
• Originally, the FDA required that mifepristone only be dispensed in person by a certified physician after

Summary: The Assembly Business and Professions Committee heard a full agenda of bills focused on reproductive health, professional licensing and sunset reviews, consumer protection, and business regulation. Early testimony centered on AB 260, which would protect access to medication abortion, mifepristone, and telehealth reproductive care in California; supporters emphasized state protections against federal restrictions, while an opponent argued the bill removed safety safeguards. The committee also heard AB 714 on closing a loophole in regulation of low-cost commercial driving schools, AB 968 on allowing pharmacists to prescribe non-hormonal contraception, AB 671 on streamlining restaurant permitting, AB 1027 on strengthening cannabis product testing oversight, AB 1271 on broadband pricing and speed transparency, and AB 1332 on narrowly allowing medicinal cannabis shipments for seriously ill patients. Several sunset bills were also taken up, including AB 1482 on animal shelter and breeder transparency, AB 1501 on the Podiatric Medical Board and Physician Assistant Board, AB 1502 on the Veterinary Medical Board, AB 1503 on the Board of Pharmacy, and AB 1504 on the Massage Therapy Council. Testimony was largely in support of the measures, with many bills drawing co-sponsors or support from industry, consumer, or professional groups. AB 1503 generated the most sustained opposition, with nurses, physicians, and drug industry representatives objecting to expanded pharmacy technician ratios, standard-of-care language, and therapeutic interchange authority; supporters argued the bill would modernize pharmacy practice and expand access. AB 1504 also drew mixed testimony, with massage therapy groups supporting continuation of the council but raising concerns about proposed public records and governance provisions. AB 1271 drew a policy dispute over whether broadband reporting requirements duplicated federal FCC processes, while supporters argued California needed its own consumer-facing data and complaint system. After quorum was established later in the hearing, the committee began taking roll-call votes. AB 1271, AB 1332, AB 1482, AB 1501, and AB 1502 were all reported out on due-pass motions, with AB 1271 amended and the others generally amended or as introduced as noted. Earlier bills including AB 260, AB 671, AB 714, AB 968, and AB 1027 also received motions and were approved once the quorum was present. The chair repeatedly noted the lack of quorum during the hearing, but once one was secured, the committee completed votes on the agenda items and advanced the measures to Appropriations.

Transcript Highlights:

• Administration of mifepristone and misoprostol is essential to protecting care here in California for
• It protects access to medication abortion here in California, specifically mifepristone, a common and
• We know that restricting access to medication abortion, and specifically mifepristone, is a priority
• There is no scientific basis for restricting access to mifepristone.
• We talked about mifepristone and misoprostol. So let's talk about what mifepristone actually does.

Summary: The Assembly Health Committee met on April 8 and heard a long series of bills, beginning with AB 54 on medication abortion access. The author and supporters, including the Attorney General’s office and reproductive justice advocates, said the bill would protect California’s medication abortion supply chain and shield providers and manufacturers from civil, criminal, and professional liability. Opponents from the California Family Council argued the bill removes safeguards and increases risks. The bill was moved forward on a committee motion. The committee then heard several reproductive and public health measures, including AB 551 to create a pilot program supporting emergency departments in providing reproductive health services, AB 260 to protect medication abortion access and telehealth, AB 309 to remove sunset dates on laws allowing pharmacy syringe sales and lawful possession of sterile syringes, AB 536 to preserve colorectal cancer screening coverage if federal guidelines are challenged, AB 804 to make housing support services a Medi-Cal benefit, AB 594 to address student health insurance billing and transparency, AB 836 to study and expand the midwifery workforce, AB 1418 to collect data on health coverage for eligible employees, and AB 1500 to maintain and expand the abortion.ca.gov information site. Supporters emphasized access, preventive care, workforce shortages, and public health benefits, while opponents raised concerns about abortion, syringe distribution, and the focus of state resources. Most measures were advanced by committee vote, with roll calls showing broad support and a few no votes from members on some bills. The final bill discussed in the transcript was AB 1037, which would update substance use disorder laws to reflect evidence-based, harm-reduction approaches and remove barriers to treatment. The author and supporters described it as a compassionate response to overdose and treatment access problems, while law enforcement opposition argued it would encourage drug use and endanger communities. The transcript cuts off during testimony on AB 1037, so no final committee action on that bill is shown in the provided text.

Transcript Highlights:

• The murder of someone being coerced to take mifepristone is deeply disturbing, and I might even suggest
• I have no preconceived plans. on mifepristone policy except to take a solid hard look at the data and
• Have you reviewed the data, and do you agree that Mifepristone is safe and effective?
• I am very familiar with Mifepristone and I did review those studies including two surveys of patients
• And then, you know, also we've had the discussion about the REMS process for Mifepristone.

Keywords: nominations, labor, health, veterans, Social Security, Elon Musk, transparency, government accountability

Summary: The meeting primarily focused on various executive nominations and their implications on labor and health affairs. Significant discussions surrounded the nomination of Mr. Sonderling as the Deputy Secretary of Labor, with members expressing concerns about workforce cuts affecting veterans and Social Security employees. There was also a debate led by a member regarding the authority and influence of private individuals, specifically citing Elon Musk's involvement in government decisions. Such discussions raised questions about transparency and accountability within governmental agencies, leading to a proposal for Mr. Musk to provide testimony before the committee.

Transcript Highlights:

• The importation of misoprostol and mifepristone for the purposes of producing an abortion is already
• Scary stories about experiences of women who've taken. misoprostol and mifepristone, or so we hear.
• You recall what these drugs do, Mifepristone, the first drug, is taken, and it causes the lining of the
• stress that the FDA, we've heard the FDA invoked a number of times, does not recommend buying Mifepristone
• Event within 45 days following a Mifepristone abortion.

Bills: SB 8, SB 1, SB 2, SB 5, SB 10, HB27, HB7, HB17, HB1, SB 9, SB 7, SB 17, SB 4, HB20, HB18, HB7, HB17, HB1, HB20, HB18, SB9, SB7, SB17, SB4, SB1, SR85, SR87, SB8, SB5, SB2, SB10, HB27

Keywords: sex designation, restroom access, civil penalties, private civil right of action, women's privacy, campground safety, youth camp regulations, flood safety, emergency evacuation, health and safety standards, disaster relief, flood preparedness, emergency funding, local government support, meteorological forecasting, abortion, healthcare, jurisdiction, civil action, qui tam

Transcript Highlights:

• In addition to utilizing the state stockpile of mifepristone, we are living in a moment where access
• Mifepristone and gender-affirming care medications are at the very center of this assault.
• Mifepristone has been targeted relentlessly by the Trump administration, and it is now under a legal
• 29 in this supplemental budget, Massachusetts is taking the necessary steps to ensure access to mifepristone
• Just as mifepristone became the next target after Roe, gender-affirming medications will be the next

Keywords: 995, all

Summary: The Senate considered a series of amendments to a supplemental appropriations bill and related measures, with several adopted and several rejected or withdrawn. Early amendments on equitable approaches to public safety and a Holyoke local account clarification failed, while amendments providing $2.5 million for Massachusetts League of Community Health Centers technical assistance and expanding access to gender-affirming medications and mifepristone were adopted. The chamber also adopted a technical amendment on alternative protein grants, a clarification to ETF modernization, and an energy storage systems amendment. Other proposals on homeowner protections, La Casa funding, emergency contract reform, an energy dashboard, EV charging ratepayer impacts, hate crimes, distressed hospital payments, and task force membership were rejected or withdrawn. A substantial portion of the debate focused on health care, food assistance, and public safety. Senators spoke in support of funding for community health centers, hospital relief, and EBT anti-skimming protections, including $15.5 million for chip-enabled EBT cards and related replacement-benefit support. One amendment to strengthen protections against impersonating federal officers was rejected, while another on professional protections was withdrawn after discussion of ballot address privacy and security concerns. The Senate also adopted amendments to continue prior appropriations for a North Shore food pantry and drought management efforts, and it later approved a sick leave bank for a Department of Mental Health employee. The chamber then took up the fiscal year 2025 fair share supplemental budget conference report, which Ways and Means described as $1.39 billion in spending split between transportation and education, including MBTA improvements, Chapter 90 aid, regional transit authorities, special education circuit breaker reimbursements, higher education deferred maintenance, and career technical education capital grants. After a roll call, the bill passed, with one recorded negative vote. The Senate also adopted a separate Ways and Means amendment and ordered the bill to third reading before final passage. The session ended with adjournment motions and a moment of silence honoring Melissa and Mark Hortman and other victims of political violence, along with a memorial adjournment for firefighter Jeffrey DeSanchez.

Transcript Highlights:

• Mifepristone and misoprostol are safe, effective medications that are also used for other indications
• Mifepristone and misoprostol are safe, effective medications that are also used for other indications
• Mifepristone and misoprostol are safe, effective medications that are also used for other indications
• Mifepristone and misoprostol are safe, effective medications that are also used for other indications
• Mifepristone alone will not always cause an abortion.

Keywords: 1189, house, all

Transcript Highlights:

• Mifepristone, which is a synthetic drug, essentially is the anti-progesterone.
• This chart is showing the embryo survival rate after a woman receives mifepristone and progesterone.
• This black line is the embryo survival rate after mifepristone alone.
• Further, mifepristone, the drug used in a chemical abortion, is not medication.
• Mifepristone ends pregnancy. It is not a medication that cures it.

Keywords: 995, all

Summary: The committee opened by explaining hearing procedures and time limits, then heard testimony on House 2499, a bill to create a public awareness campaign on menopause and related midlife health issues. Supporters, including a nurse, the Massachusetts Commission on the Status of Women, and other advocates, said menopause is widely misunderstood by patients and providers, leading to delayed care, unnecessary suffering, workplace impacts, and inequities in women’s health. Several speakers shared personal experiences with symptoms being dismissed or misdiagnosed and urged the committee to advance the bill. The committee then took testimony on a package of endometriosis bills, including House 2527 and Senate 1564, calling for a task force and broader awareness efforts. Patients, a physician, and advocates described long diagnostic delays, severe pain, infertility, medical gaslighting, and limited access to specialists and effective treatment. They argued for more research, provider education, and a coordinated state strategy, and several asked for favorable reports. The chair also noted the hearing was running behind and extended time to allow more testimony. Later, the committee heard Senate 1579, which would eliminate parental consent and judicial bypass requirements for abortion access for minors under 16. Planned Parenthood representatives, physicians, legal advocates, and students argued the current law creates unnecessary delays and harms vulnerable youth, especially those in unsafe homes or foster care, while supporters said minors can already consent to other reproductive health care. A pro-life witness opposed the bill and emphasized parental involvement and support services. The committee also heard House 2403 and Senate 1560, which would create a Human Service Transportation Consumer Advisory Board; disability advocates and riders described past safety problems and current service gaps, and supported the board as a low-cost way to improve accountability, rider input, and reliability. No votes or final actions were taken in the excerpt.

Transcript Highlights:

• The primary medications that we're addressing are mifepristone and misoprostol.
• You may not know about the history of the development of mifepristone.

Transcript Highlights:

• Uh, the primary medic medications that we're addressing are mifepristone and misoprostol.
• Um, you may not know about the history of the development of mifepristone.

Transcript Highlights:

• The first drug, Mifepristone, it comes from the United States.
• In 2000, my goodness, over 20 years ago, Mifepristone was only approved by the FDA under what they call
• Policy Center did the largest known U.S. study of abortion pills in history: 165,727 prescribed Mifepristone
• The recent study shows that Mifepristone causes more complications than this incomplete FDA data suggests

Bills: SB 2, SB 5, SB 10, SB 9, SB 7, SB 17, SB 4, HB17, HB7, HB7, HB15, HB15, HB27, HB1, HB7, HB15, HB18, SB9, SB7, SB17, SB4, HB17, HB27, HB1, SB8, HCR13, SB2, SB5, SB10

Keywords: disaster relief, flood preparedness, emergency funding, local government support, meteorological forecasting, school assessment, public education, accountability, transparency, education standards, STAAR, Texas Education Agency, TEA, public school accountability, school ratings, A-F ratings, assessment reform, student testing, benchmark tests, interim assessments

Transcript Highlights:

• The first drug in the abortion regimen, mifepristone, causes the lining of the uterus to thin and keeps
• According to the FDA, mifepristone has caused 36 known deaths since its approval.
• Hemorrhaging or another serious adverse event within 45 days following a mifepristone abortion.
• The real-world rate of serious adverse events following mifepristone abortions is at least 22 times as
• Another recent study affirms that mifepristone causes more complications than the FDA data suggests.

Summary: The Senate began with a quorum call, prayer, approval of the previous journal, and messages from the House, then moved through several recognitions and resolutions honoring visiting groups. Members adopted resolutions recognizing the Texas chapters of Blue Star Mothers of America, Fine Arts Education Day, Donate Life Texas Day, Baha’i Capitol Day, County Government Day, Jack County Day, Crockett County Day, and a recognition of Navy Petty Officer Simon Urbanik for service during the Cuban Missile Crisis. The chamber also heard remarks from visiting doctors, students, county officials, and community groups, with multiple senators speaking in support of military families, arts education, organ donation, and local government service. The Senate then took up Committee Substitute Senate Bill 2779, relating to the allocation and use of certain hotel occupancy tax revenues. Senator Birdwell said the bill would stop local governments from conditioning HOT funds on race- or class-based priorities and would require Galveston to transfer the full state rebate for beach cleaning and maintenance to its park board. After questions, the Senate suspended the rules, passed the bill to engrossment, suspended the three-day rule, and finally passed it, though the final vote showed significant opposition. The chamber also passed Committee Substitute Senate Bill 2322, described as a cleanup bill removing the compelling-factor test for dispatchable generation from the Texas Jobs, Energy, Technology, and Innovation Act. A major debate centered on Committee Substitute Senate Bill 2253, which would phase out uncertified teachers in core classrooms and strengthen educator certification requirements. Senator Creighton argued the bill responds to a teacher pipeline crisis, adds parent notification, creates multiple preparation pathways, and provides financial incentives for certification; Senator West and Senator Sparks pressed for rural flexibility and implementation details. An amendment from Senator Gutierrez to add a teacher student-loan repayment program failed on a 11-17 vote, while other technical and fiscal amendments were adopted. The bill then passed to engrossment, the three-day rule was suspended, and it was finally passed. The Senate also passed Committee Substitute Senate Bill 2371, updating skimmer-reporting rules to cover electronic terminals beyond fuel pumps, and Committee Substitute Senate Bill 2351, relating to the construction of certain concrete plants under a standard permit. Senate Bill 619, a conscience-protection bill for health care workers, drew extended questioning from Senators Cook, Eckhardt, and Menendez about patient abandonment, scope, and whether it could allow refusals of legal services such as vaccines, antibiotics, contraception, or personal care; despite those concerns, the Senate suspended the rules and passed the bill to engrossment. Finally, the chamber began consideration of Committee Substitute Senate Bill 1169, which would allow public entities to form public utility agencies to cooperate on water and wastewater projects without eminent domain or cross-collateralization, with Senator Hinojosa explaining it as a tool for small and rural communities facing utility infrastructure problems.

Transcript Highlights:

• The abortion pill is Mifepristone, and yes, it was approved by the Food and Drug Administration.
• I have seen Mifepristone and misoprostol save lives.
• Mifepristone is being claimed to be safer than Tums or ibuprofen.
• On the other hand, around 3 million women have used mifepristone since its approval in 2000.
• We know that approximately one person dies with nearly every single use of mifepristone.

Bills: HB229, HB229, HB3990, HB5082, HB5510

Keywords: HB 229, Texas, political subdivision, local government, county dues, county association, state association of counties, lobbying, lobbyist, public funds, taxpayer lawsuit, injunctive relief, attorney's fees, Government Code Chapter 556, Local Government Code Section 89.002, legislative advocacy, municipal government, county government, city government, special district

Transcript Highlights:

• Kennedy has indicated he's open to restricting access to the abortion medication Mifepristone, which
• Mifepristone is safe.
• You said just now the discussion about Mifepristone. Oh, he's asked me to study the safety of it.
• Here are the safety studies that tell us Mifepristone is safe and effective. And I ask, Mr.
• And what is clear to me is that you and President Trump are dangerous to women's access to Mifepristone

Transcript Highlights:

• AB 54 focuses on the abortion pills mifepristone and misoprostol, and yet ignores the brutal reality
• First, mifepristone chemically starves a pre-born child of the vital hormone progesterone, causing the
• A new study released by the Ethics and Public Policy Center analyzed 865,727 mifepristone abortions from
• For example, Louisiana is using PDMP data to track mifepristone prescriptions, as the state has passed
• First, it prohibits the reporting of testosterone and mifepristone to CURES.

Summary: The committee heard testimony on several bills related to reproductive access, child safety online, immigration enforcement in schools, health privacy, location data, digital provenance, reparations, and age assurance. AB 54 would protect the medication abortion supply chain and shield providers and others from liability; AB 1137 would strengthen reporting and enforcement tools for child sexual abuse material on social media; AB 49 would limit ICE activity at California public schools; AB 82 would expand privacy and safety protections for gender-affirming care patients and providers; AB 1355 would restrict the collection, use, and sale of precise location data; AB 853 would expand provenance requirements for AI-generated and authentic content; AB 62 would create a pathway for restitution for racially biased eminent domain takings; and AB 1043 would create a device-based age assurance framework for online services. Supporters generally framed the bills as necessary responses to current harms: reproductive rights advocates emphasized California’s role as a safe haven; child safety witnesses described the persistence and re-victimization caused by CSAM online; immigrant rights and education advocates said schools should remain safe from immigration enforcement; health and LGBTQ+ advocates stressed privacy and safety risks tied to tracking and harassment; privacy and consumer groups backed limits on location data and stronger provenance tools; and reparations advocates said AB 62 would help address historic injustices. Opposition came from family policy, tech, business, law enforcement, and industry groups, who raised concerns about safety claims, constitutional issues, implementation burdens, transparency, law enforcement access, and the need to preserve existing privacy frameworks and voluntary standards. The committee members largely expressed support for the policy goals while noting implementation concerns on some measures. Several members asked for or were offered coauthor status on bills. AB 1137, AB 54, AB 49, AB 82, AB 1355, AB 853, and AB 62 all received do-pass votes to Appropriations, with some members voting no or not voting on certain bills. AB 1355 and AB 853 were advanced with amendments or ongoing work promised with opponents, and AB 1043 was presented with discussion of possible amendments on parental consent and age assurance details, though the transcript cuts off before final action on that bill.